Friday, July 31, 2026

U.S. Flags South Korea Over AI Infrastructure Bidding in Annual Trade Barriers Report

The US report shows an increase in trade barriers for South Korea compared to other countries over the past year.

North Korea Slams U.S. Troop Flexibility Plan as ‘Hegemonic War Playbook’

North Korea criticizes U.S. plans for USFK expansion, warning it could escalate conflicts in Northeast Asia and threaten regional stability.

Ministry of Unification: “Did Not Attend South Korea-US ‘Regular Consultation’… North Korea Policy Discussed Separately with the US”

The Unification Ministry will not attend U.S.-South Korea talks on North Korea policy, emphasizing its separate role in inter-Korean dialogue.

Tag: Keytruda

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Unlocking Cancer Treatment: Samsung Bioepis Achieves Keytruda Biosimilar Equivalence in Global Trials

Samsung Bioepis' biosimilar SB27 shows equivalence to Keytruda in key clinical trials, enhancing access to cancer immunotherapy.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

How Keytruda is Revolutionizing Cancer Treatment: Expanded Coverage for Stomach Cancer in 2026

Keytruda's insurance coverage expands to stomach cancer, solidifying its status as a leading universal immunotherapy for various cancers.

Opdivo Wins EU Approval in Big Step for Early Lung Cancer Treatment

Opdivo gains EU approval for perioperative therapy in NSCLC, enhancing competition with Keytruda and marking a treatment paradigm shift.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.